Cargando…
Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implications
HCC represents the sixth most common cancer worldwide and the second leading cause of cancer-related death. Despite the high incidence, treatment options for advanced HCC remain limited and unsuccessful, resulting in a poor prognosis. Despite the major advances achieved in the diagnostic management...
Autores principales: | Berretta, Massimiliano, Cavaliere, Carla, Alessandrini, Lara, Stanzione, Brigida, Facchini, Gaetano, Balestreri, Luca, Perin, Tiziana, Canzonieri, Vincenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355172/ https://www.ncbi.nlm.nih.gov/pubmed/28077782 http://dx.doi.org/10.18632/oncotarget.13929 |
Ejemplares similares
-
Serum Markers of Intrahepatic Cholangiocarcinoma
por: Malaguarnera, Giulia, et al.
Publicado: (2013) -
Extramammary Paget disease of the vulva: immunohistochemical analysis of neoangiogenesis and epithelial-mesenchymal transition markers expression
por: Alessandrini, Lara, et al.
Publicado: (2018) -
Primary extragenital endometrial stromal sarcoma of the lung: first reported case and review of literature
por: Alessandrini, Lara, et al.
Publicado: (2017) -
Angiogenesis Inhibitors for the Treatment of Hepatocellular Carcinoma
por: Berretta, Massimiliano, et al.
Publicado: (2016) -
Carcinogenetic mechanisms of endocrine disruptors in female cancers (Review)
por: Del Pup, Lino, et al.
Publicado: (2016)